What question did this study set out to answer?

To explore how extemporaneous formulations can address the challenges in pharmaceutical manufacturing for personalized medicines.

February 8, 2026Pharmaceutics0 citationsOpen Access

Extemporaneous Formulations: Filling the Gap in the Pharmaceutical Industry with Personalized Medicines

ALAntonio LopalcoUniversity of Bari Aldo Moro NDNunzio DenoraIstituto di Farmacologia Traslazionale

Key Points

To explore how extemporaneous formulations can address the challenges in pharmaceutical manufacturing for personalized medicines.
Analyzed current pharmaceutical manufacturing processes
Evaluated the benefits of personalized versus standardized medicines
Identified gaps in existing therapeutic strategies
Personalized medicines demonstrate higher patient satisfaction and effectiveness
Standardized processes are insufficient for diverse patient needs
Extemporaneous formulations can enhance treatment options and support individualized care

Abstract

The progressive shift of healthcare systems toward personalised and patient-centred therapeutic strategies has exposed the structural limitations of standardised pharmaceutical manufacturing ...

问 AI

Bookmark

View Full Paper

Cite This Study

Lopalco et al. (Fri,) studied this question.

synapsesocial.com/papers/698828530fc35cd7a8847b32 https://doi.org/https://doi.org/10.3390/pharmaceutics18020209

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

问 AI

Bookmark

View Full Paper